BusinessCancer Genetics, Inc. is Among the First To Drive New FDA-Approved Testing Paradigm for Non-Small Cell Lung Cancer Patients by Offering Thermo Fisher Scientific’s Oncomine Dx Target TestBy Nasdaq OMXNov 2, 2017, 11:30 AM UTC
BusinessCancer Genetics, Inc. to Host Panel Discussion on “The Convergence of Artificial Intelligence and Healthcare - New Developments in Precision Medicine” During the 3rd Annual Dawson James Small Cap Growth Conference on October 18thBy Nasdaq OMXOct 12, 2017, 11:30 AM UTC
BusinessAmerican Health Council Names Carlos Encarnacion, M.D. to Physician BoardBy Nasdaq OMXDec 14, 2016, 4:37 PM UTC
